• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童肠道对药物的代谢及转运:年龄与疾病的影响

Intestinal metabolism and transport of drugs in children: the effects of age and disease.

作者信息

Johnson Trevor N, Thomson Mike

机构信息

Pharmacy Department, Sheffield Children's Hospital, Western Bank, Sheffield S10 2TH, UK.

出版信息

J Pediatr Gastroenterol Nutr. 2008 Jul;47(1):3-10. doi: 10.1097/MPG.0b013e31816a8cca.

DOI:10.1097/MPG.0b013e31816a8cca
PMID:18607262
Abstract

The presence of cytochrome P450 enzymes in the small bowel results in the reduced bioavailability of several drugs. Recently, there has been much research on the interplay between these enzymes and transporter proteins such as P-glycoprotein. Intestinal drug metabolism not only has an effect on drug disposition but also may have a role in protecting the host from xenobiotics. Although there is some information on how both the enzymes and transporters develop in the small bowel with age, there is little information regarding the clinical effects of these changes. In addition to developmental changes, the influence of gastrointestinal disease and nutrition are additional covariates in the intestinal metabolism of drugs.

摘要

小肠中细胞色素P450酶的存在会导致几种药物的生物利用度降低。最近,对这些酶与转运蛋白(如P-糖蛋白)之间的相互作用进行了大量研究。肠道药物代谢不仅会影响药物处置,还可能在保护宿主免受外源性物质影响方面发挥作用。尽管有一些关于这些酶和转运蛋白如何随年龄在小肠中发育的信息,但关于这些变化的临床影响的信息却很少。除了发育变化外,胃肠道疾病和营养的影响是药物肠道代谢中的其他协变量。

相似文献

1
Intestinal metabolism and transport of drugs in children: the effects of age and disease.儿童肠道对药物的代谢及转运:年龄与疾病的影响
J Pediatr Gastroenterol Nutr. 2008 Jul;47(1):3-10. doi: 10.1097/MPG.0b013e31816a8cca.
2
[Drug metabolism in the small intestine--the significance for biological availability].[小肠中的药物代谢——对生物利用度的意义]
Ugeskr Laeger. 2000 May 29;162(22):3215-9.
3
The metabolism of midazolam and comparison with other CYP enzyme substrates during intestinal absorption: in vitro studies with rat everted gut sacs.咪达唑仑在肠道吸收过程中的代谢及其与其他细胞色素P450酶底物的比较:大鼠外翻肠囊的体外研究
J Pharm Pharm Sci. 2007;10(1):26-36.
4
Cytochrome P450-mediated metabolism in the human gut wall.细胞色素P450介导的人体肠壁代谢。
J Pharm Pharmacol. 2009 May;61(5):541-58. doi: 10.1211/jpp/61.05.0002.
5
Inhibitory effect of docosahexaenoic acid (DHA) on the intestinal metabolism of midazolam: in vitro and in vivo studies in rats.二十二碳六烯酸(DHA)对咪达唑仑肠道代谢的抑制作用:大鼠的体外和体内研究
Int J Pharm. 2008 Mar 3;351(1-2):133-43. doi: 10.1016/j.ijpharm.2007.09.037. Epub 2007 Oct 5.
6
Asymmetric intestinal first-pass metabolism causes minimal oral bioavailability of midazolam in cynomolgus monkey.非对称的肠道首过代谢导致咪达唑仑在食蟹猴中的口服生物利用度极低。
Drug Metab Dispos. 2007 Aug;35(8):1275-84. doi: 10.1124/dmd.106.013037. Epub 2007 Apr 30.
7
Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells.大鼠肝脏缺血再灌注损伤后环孢素A口服吸收减少:CYP3A和P-糖蛋白在肠上皮细胞首过代谢中的作用
J Pharmacol Exp Ther. 2009 Jan;328(1):249-55. doi: 10.1124/jpet.108.145581. Epub 2008 Oct 8.
8
Drug metabolism by cytochromes P450 in the liver and small bowel.肝脏和小肠中细胞色素P450介导的药物代谢。
Gastroenterol Clin North Am. 1992 Sep;21(3):511-26.
9
[Interactions between food and drugs. 2. Disturbances of drug metabolism and synergistic mode of action].[食物与药物的相互作用。2. 药物代谢紊乱及协同作用模式]
Pol Merkur Lekarski. 2000 Nov;9(53):795-8.
10
Recent advances in cyclosporine pharmacokinetics.环孢素药代动力学的最新进展。
Pharmacotherapy. 1991;11(5):130S-134S.

引用本文的文献

1
Beta-blockers and breastfeeding: a real-life prospective study.β受体阻滞剂与母乳喂养:一项真实世界的前瞻性研究。
Eur J Clin Pharmacol. 2024 Dec;80(12):1937-1943. doi: 10.1007/s00228-024-03753-y. Epub 2024 Sep 11.
2
Recent advances in the ontogeny of drug disposition.药物处置的个体发育中最近的进展。
Br J Clin Pharmacol. 2022 Oct;88(10):4267-4284. doi: 10.1111/bcp.14821. Epub 2021 Apr 15.
3
Mind the Gaps: Ontogeny of Human Brain P-gp and Its Impact on Drug Toxicity.注意差距:人类大脑 P-糖蛋白的个体发生及其对药物毒性的影响。
AAPS J. 2019 May 28;21(4):67. doi: 10.1208/s12248-019-0340-z.
4
Model Informed Pediatric Development Applied to Bilastine: Ontogenic PK Model Development, Dose Selection for First Time in Children and PK Study Design.模型指导下的儿科药物研发在比拉斯汀中的应用:成长期药代动力学模型的建立、儿童首次用药剂量选择和药代动力学研究设计。
Pharm Res. 2017 Dec;34(12):2720-2734. doi: 10.1007/s11095-017-2248-6. Epub 2017 Oct 2.
5
In vitro Phase I- and Phase II-Drug Metabolism in The Liver of Juvenile and Adult Göttingen Minipigs.幼年和成年哥廷根小型猪肝脏中的体外I期和II期药物代谢
Pharm Res. 2017 Apr;34(4):750-764. doi: 10.1007/s11095-017-2101-y. Epub 2017 Jan 17.
6
Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions.儿科口服药物吸收:肠壁、其发育变化及当前的预测工具
Biopharm Drug Dispos. 2017 Apr;38(3):209-230. doi: 10.1002/bdd.2052. Epub 2017 Feb 6.
7
Influence of Food on Paediatric Gastrointestinal Drug Absorption Following Oral Administration: A Review.食物对小儿口服胃肠道药物吸收的影响:综述
Children (Basel). 2015 Jun 9;2(2):244-71. doi: 10.3390/children2020244.
8
Global marine pollutants inhibit P-glycoprotein: Environmental levels, inhibitory effects, and cocrystal structure.全球海洋污染物抑制P-糖蛋白:环境水平、抑制作用及共晶体结构
Sci Adv. 2016 Apr 15;2(4):e1600001. doi: 10.1126/sciadv.1600001. eCollection 2016 Apr.
9
Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future.新生儿用药的药代动力学:循证依据、范例与未来
Br J Clin Pharmacol. 2015 Dec;80(6):1281-8. doi: 10.1111/bcp.12741. Epub 2015 Oct 26.
10
Development of a Pediatric Physiologically Based Pharmacokinetic Model for Sirolimus: Applying Principles of Growth and Maturation in Neonates and Infants.西罗莫司儿科生理药代动力学模型的开发:应用新生儿和婴儿生长与成熟的原理
CPT Pharmacometrics Syst Pharmacol. 2015 Feb;4(2):e17. doi: 10.1002/psp4.17. Epub 2015 Feb 4.